Statera BioPharma (STU:7CB) Total Stockholders Equity : €-10.34 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Total Stockholders Equity?

Statera BioPharma's Total Stockholders Equity for the quarter that ended in Sep. 2022 was €-10.34 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Statera BioPharma's Book Value per Share for the quarter that ended in Sep. 2022 was €-0.21. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Statera BioPharma's Debt-to-Equity for the quarter that ended in Sep. 2022 was -0.72.

Statera BioPharma Total Stockholders Equity Historical Data

The historical data trend for Statera BioPharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Total Stockholders Equity Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Total Stockholders Equity

-3.79

-3.01

-1.39

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Stockholders Equity	Get a 7-Day Free Trial						63.00	-1.39	-2.26	-6.61	-10.34

Statera BioPharma (STU:7CB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Statera BioPharma's Book Value per Share for the quarter that ended in Sep. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-10.343	-	0)	/	50.234
	=	-0.21

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Statera BioPharma's Debt-to-Equity for the quarter that ended in Sep. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.787	+	0.693)	/	-10.343
	=	-0.72

Statera BioPharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines